flumazenil has been researched along with framycetin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Carmona Soria, I; García Montes, JM; Herrerías Gutiérrez, JM; Jiménez Sáenz, M; Quero Guillén, JC | 1 |
Córdoba Cardona, J; García Martínez, R | 1 |
1 review(s) available for flumazenil and framycetin
Article | Year |
---|---|
[Update on the management of hepatic encephalopathy].
Topics: Aged; Ammonia; Anti-Bacterial Agents; Antidotes; Clinical Trials as Topic; Dialysis; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Liver Transplantation; Meta-Analysis as Topic; Neomycin; Protein Synthesis Inhibitors; Rifamycins; Risk Factors | 2008 |
3 other study(ies) available for flumazenil and framycetin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bromocriptine; Dipeptides; Dopamine Agonists; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure, Acute; Liver Transplantation; Neomycin; Nutritional Physiological Phenomena; Practice Guidelines as Topic; Prognosis; Sodium Benzoate; Terminology as Topic; Time Factors; Zinc | 2003 |